Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2014 1
2015 3
2016 1
2017 3
2018 4
2019 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Breastfeeding in Gaucher disease: is enzyme replacement therapy safe?
Dornelles AD, de Oliveira Netto CB, Vairo F, de Mari JF, Tirelli KM, Schwartz IV. Dornelles AD, et al. Among authors: de oliveira netto cb. Clin Ther. 2014 Jun 1;36(6):990-1. doi: 10.1016/j.clinthera.2014.03.017. Epub 2014 Apr 24. Clin Ther. 2014. PMID: 24768190 No abstract available.
Screening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeast.
Felicio PS, Alemar B, Coelho AS, Berardinelli GN, Melendez ME, Lengert AVH, Miche Lli RD, Reis RM, Fernandes GC, Ewald IP, Bittar CM, Netto CBO, Artigalas O, Peixoto A, Pinheiro M, Teixeira MR, Vargas FR, Dos Santos ACE, Moreira MAM, Ashton-Prolla P, Palmero EI. Felicio PS, et al. Among authors: netto cbo. Cancer Genet. 2018 Dec;228-229:93-97. doi: 10.1016/j.cancergen.2018.09.001. Epub 2018 Oct 6. Cancer Genet. 2018. PMID: 30553478
Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
Andreis TF, de Souza KIW, Vieira IA, Alemar B, Sinigaglia M, de Araújo Rocha YM, Artigalás O, Bittar C, Oliveira Netto CB, Ashton-Prolla P, Rosset C. Andreis TF, et al. Among authors: oliveira netto cb. Gene. 2023 Apr 30;862:147281. doi: 10.1016/j.gene.2023.147281. Epub 2023 Feb 10. Gene. 2023. PMID: 36775216
TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
Hahn EC, Bittar CM, Vianna FSL, Netto CBO, Biazús JV, Cericatto R, Cavalheiro JA, de Melo MP, Menke CH, Rabin E, Leistner-Segal S, Ashton-Prolla P. Hahn EC, et al. Among authors: netto cbo. PLoS One. 2018 Dec 31;13(12):e0209934. doi: 10.1371/journal.pone.0209934. eCollection 2018. PLoS One. 2018. PMID: 30596752 Free PMC article. Clinical Trial.
DNA damage in Fabry patients: An investigation of oxidative damage and repair.
Biancini GB, Moura DJ, Manini PR, Faverzani JL, Netto CB, Deon M, Giugliani R, Saffi J, Vargas CR. Biancini GB, et al. Among authors: netto cb. Mutat Res Genet Toxicol Environ Mutagen. 2015 Jun;784-785:31-6. doi: 10.1016/j.mrgentox.2015.04.012. Epub 2015 Apr 28. Mutat Res Genet Toxicol Environ Mutagen. 2015. PMID: 26046974
18 results